
    
      An open label, balanced, randomized, two-treatment, two-period, two-sequence, single oral
      dose, crossover, bioequivalence study of Olanzapine Tablets 5 mg of Dr. Reddy's Laboratories
      Limited, India, comparing with that of ZyprexaÂ® (Olanzapine) Tablets 5 mg of Eli Lilly and
      Company, USA, in healthy, adult, human subjects under fed conditions.
    
  